We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

53 hedge funds and large institutions have $3.94M invested in Envoy Medical Warrant in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

7% less funds holding

Funds holding: 57 → 53 (-4)

55% less capital invested

Capital invested by funds: $8.83M → $3.94M (-$4.89M)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
53
Holders Change
-4
Holders Change %
-7.02%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
8
Closed
6
Calls
$7.17M
Puts
–
Net Calls
+$7.17M
Net Calls Change
+$511K

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$28.7K
2
CF
Cantor Fitzgerald
New York
+$21.5K
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$10K
4
Man Group
Man Group
United Kingdom
+$8.01K
5
CCMU
Cheyne Capital Management (UK)
United Kingdom
+$6.64K

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$298K
2
HHAM
HITE Hedge Asset Management
Massachusetts
-$242K
3
GCL
Glazer Capital LLC
New York
-$158K
4
ICMH
Integrity Capital Management (HK)
Hong Kong
-$39K
5
KPF
K2 Principal Fund
Ontario, Canada
-$39K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.63M – – –
SCM
2
Segantii Capital Management
Hong Kong
$492K – – –
AC
3
Athos Capital
Hong Kong
$328K – – –
AC
4
Aristeia Capital
Connecticut
$212K – – –
Nomura Holdings
5
Nomura Holdings
Japan
$171K – – –
FTCM
6
Fir Tree Capital Management
New York
$97K – – –
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$74K – – –
PC
8
Periscope Capital
Ontario, Canada
$72K – – –
Man Group
9
Man Group
United Kingdom
$61K +$8.01K +18,600 +8%
WP
10
Woodline Partners
California
$56K +$28.7K +66,666 +42%
AC
11
Antara Capital
New York
$48K – – –
WA
12
Whitebox Advisors
Minnesota
$46K -$6.89K -16,000 -8%
SC
13
Sculptor Capital
New York
$44K – – –
TCA
14
Taconic Capital Advisors
New York
$42K – – –
MCM
15
Moore Capital Management
New York
$40K – – –
SCC
16
Spring Creek Capital
Kansas
$40K – – –
VI
17
Vestcor Inc
New Brunswick, Canada
$40K – – –
RIA
18
RP Investment Advisors
Ontario, Canada
$35K +$1.4K +3,243 +2%
EH
19
EMG Holdings
Connecticut
$34K – – –
Goldman Sachs
20
Goldman Sachs
New York
$31K – – –
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$27K – – –
KJHP
22
K.J. Harrison & Partners
Ontario, Canada
$25K +$6.54K +15,200 +18%
DCM
23
Dupont Capital Management
Delaware
$24K – – –
CCA
24
Castle Creek Arbitrage
Colorado
$23K – – –
CF
25
Cantor Fitzgerald
New York
$22K +$21.5K +49,853 +114%
1
2 3

COCHW Hedge Fund Activity: Q1 2022 in Review

53 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q1 2022, worth a combined $3.94M — down 55% from $8.83M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of COCHW and 2 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 8 added.

The largest buyer was Woodline Partners, adding an estimated $28.7K. The largest seller was Linden Advisors, exiting entirely with an estimated $298K sold.

  • 53 institutional investors held Envoy Medical Warrant (COCHW) as of Q1 2022, down from 57 in Q4 2021.
  • Funds reported $3.94M of Envoy Medical Warrant stock for Q1 2022, down 55% quarter-over-quarter.
  • 2 funds opened new Envoy Medical Warrant positions in Q1 2022 and 6 closed out, a net change of -4 holders.
  • The largest Envoy Medical Warrant buyer in Q1 2022 was Woodline Partners, an estimated $28.7K added.
  • The largest Envoy Medical Warrant seller in Q1 2022 was Linden Advisors, an estimated $298K sold.

Based on aggregated 13F filings for Q1 2022.